Funding · Company
NGM Bio Holdings, Inc.
South San Francisco, CABiotech & Pharma
NGM Bio Holdings, Inc. of South San Francisco, CA has disclosed $142M across 1 Form D offering filed with the SEC on Mar 27, 2026.
$142M
Total disclosed
1
Form D offering
2024
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$142M
Form D · Mar 27, 2026 ↗
Q1 2026
· 1 amendment, first filed Jul 17, 2024
Filing details
HeadquartersSouth San Francisco, CAIndustryBiotech & Pharma (Biotechnology)Incorporated2024SEC CIK0002029767Offerings on file1
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →